Volume 15 - Issue 10 - October, 2003
Case Report
08/01/2008
Hans-Ulrich Stempfle, MD; Andreas Konig, MD; Volker Klauss, MD
Angiographically detected coronary artery aneurysms are difficult to treat; they occur with an incidence of 0.3–4.9% (2–10% after interventional procedures).1,2 They can provoke ischemia1 or myocardial infarction.3 Several cases of covered...
Angiographically detected coronary artery aneurysms are difficult to treat; they occur with an incidence of 0.3–4.9% (2–10% after interventional procedures).1,2 They can provoke ischemia1 or myocardial infarction.3 Several cases of covered...
Angiographically detected...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Michel Tessier, MD, MSc; Robert De Larochellière, MD; Olivier F. Bertrand, MD, PhD
Treatment of in-stent restenosis using catheter-based brachytherapy is an effective treatment modality. Several international randomized trials have established the safety and efficacy of different systems and isotopes.1–3 Although patients...
Treatment of in-stent restenosis using catheter-based brachytherapy is an effective treatment modality. Several international randomized trials have established the safety and efficacy of different systems and isotopes.1–3 Although patients...
Treatment of in-stent restenosis...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Rahul A. Shimpi, MD; Kenneth W. Mahaffey, MD; James E. Tcheng, MD
Profound advancements in the management of acute coronary syndromes (ACS) have been realized in recent years. Initial medical therapy for non-ST segment elevation ACS has evolved to include the use of the combined treatment modalities of...
Profound advancements in the management of acute coronary syndromes (ACS) have been realized in recent years. Initial medical therapy for non-ST segment elevation ACS has evolved to include the use of the combined treatment modalities of...
Profound advancements in the...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Chris Cates: I thought we had a tough job in interventional cardiology, but according to your presentation, it sounds like the device industry has it even tougher! Incentives within the system seem to be misaligned, and many cross-incentives...
Chris Cates: I thought we had a tough job in interventional cardiology, but according to your presentation, it sounds like the device industry has it even tougher! Incentives within the system seem to be misaligned, and many cross-incentives...
Chris Cates: I thought we had a...
08/01/2008
Journal of Invasive Cardiology
Review
08/01/2008
Ricardo A. Costa, MD, PhD; Ian R. Crocker, MD; Michel Joyal, MD; Tim Fox, PhD; Andre Arsenault, MD; Raoul Bonan, MD; Francois Harel, MD; Jean Gregoire, MD
Treatment of bifurcation lesions has been associated with lower success and higher complications rates. They represent a major interventional challenge. Redistribution of plaque (snowplow effect) often leads to occlusion of the side branch....
Treatment of bifurcation lesions has been associated with lower success and higher complications rates. They represent a major interventional challenge. Redistribution of plaque (snowplow effect) often leads to occlusion of the side branch....
Treatment of bifurcation lesions...
08/01/2008
Journal of Invasive Cardiology
Editorial Message
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers,
This issue of the Journal of Invasive Cardiology includes original research articles, case reports, case reports with brief literature reviews, articles from the Journal special sections "Practice Management and Economics", and...
Dear Readers,
This issue of the Journal of Invasive Cardiology includes original research articles, case reports, case reports with brief literature reviews, articles from the Journal special sections "Practice Management and Economics", and...
Dear Readers,
This issue of the...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Raoul Bonan, MD
It failed to be approved for the “plain” indication when the Cutting Balloon Global Randomized Trial shows no benefit over the plain balloon in pre-stenting era. In this multicenter, randomized clinical trial, cutting balloon angioplasty...
It failed to be approved for the “plain” indication when the Cutting Balloon Global Randomized Trial shows no benefit over the plain balloon in pre-stenting era. In this multicenter, randomized clinical trial, cutting balloon angioplasty...
It failed to be approved for the...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Hisataka Sasao, MD, PhD; Akita Endo, MD, PhD; Tohru Hasegawa, MD, PhD; Hiroshi Oimatsu, MD, PhD; Takehito Takada, MD, PhD
Prospective randomized trials of coronary stenting with the Palmaz-Schatz (PS) stent (Cordis Corporation, Miami, Florida) in stable angina1,2 or in acute myocardial infarction3,4 have shown a reduced incidence of cardiac events. However, the...
Prospective randomized trials of coronary stenting with the Palmaz-Schatz (PS) stent (Cordis Corporation, Miami, Florida) in stable angina1,2 or in acute myocardial infarction3,4 have shown a reduced incidence of cardiac events. However, the...
Prospective randomized trials of...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Ashraf M. Nagm, MD; John W. Moore, MD, MPH
Intravascular stent implantation is the preferred treatment for native and post-operative branch pulmonary stenosis.1–4 The standard procedure for stent placement1 includes calibrated angiography, which has been regarded as the optimal...
Intravascular stent implantation is the preferred treatment for native and post-operative branch pulmonary stenosis.1–4 The standard procedure for stent placement1 includes calibrated angiography, which has been regarded as the optimal...
Intravascular stent implantation...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Harry Suryapranata, MD, PhD; Kui-Hian Sim; Otte J. Rachman; Jeffrey D. Adipranoto; Hanafi B. Trisnohadi; Nik Ahmad; Koon-How Mak; James T. Stewart, MD; Charles N. S. Chan, MBBS; Muhammad Yusak; Peter N. Ruygrok, MD, MB, FRACP, FESC; Iwan Boestan; Teguh Santoso
The use of the antiplatelet agents ticlopidine and clopidogrel, in addition to aspirin, has been proven to reduce subacute stent thrombosis (SAT) rates to
The use of the antiplatelet agents ticlopidine and clopidogrel, in addition to aspirin, has been proven to reduce subacute stent thrombosis (SAT) rates to
The use of the antiplatelet...
08/01/2008
Journal of Invasive Cardiology
